Allogene Therapeutics Inc (ALLO)
2.19
+0.08
(+3.79%)
USD |
NASDAQ |
Nov 22, 11:45
Allogene Therapeutics Total Liabilities (Quarterly): 125.37M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 125.37M |
| June 30, 2024 | 131.84M |
| March 31, 2024 | 124.98M |
| December 31, 2023 | 130.60M |
| September 30, 2023 | 129.22M |
| June 30, 2023 | 148.06M |
| March 31, 2023 | 154.61M |
| December 31, 2022 | 154.70M |
| September 30, 2022 | 147.61M |
| June 30, 2022 | 145.70M |
| March 31, 2022 | 109.40M |
| December 31, 2021 | 125.63M |
| September 30, 2021 | 109.30M |
| Date | Value |
|---|---|
| June 30, 2021 | 102.91M |
| March 31, 2021 | 109.26M |
| December 31, 2020 | 148.21M |
| September 30, 2020 | 103.77M |
| June 30, 2020 | 95.12M |
| March 31, 2020 | 82.00M |
| December 31, 2019 | 88.78M |
| September 30, 2019 | 75.83M |
| June 30, 2019 | 78.36M |
| March 31, 2019 | 68.14M |
| December 31, 2018 | 70.69M |
| September 30, 2018 | 603.68M |
| June 30, 2018 | 17.23M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
82.00M
Minimum
Mar 2020
154.70M
Maximum
Dec 2022
123.36M
Average
125.50M
Median
Total Liabilities (Quarterly) Benchmarks
| ANI Pharmaceuticals Inc | 856.58M |
| AIM ImmunoTech Inc | 10.68M |
| Perspective Therapeutics Inc | 62.68M |
| Protalix BioTherapeutics Inc | 29.13M |
| Armata Pharmaceuticals Inc | 149.21M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 589.12M |
| Shareholders Equity (Quarterly) | 463.75M |